Nobivac® Intra-Trac®3 ADT



Canine Adenovirus Type 2, Parainfluenza, Bordetella Bronchiseptica Vaccine, MODIFIED LIVE VIRUS, AVIRULENT LIVE CULTURE


A proven 1-year intranasal vaccine that provides triple protection against the agents implicated in the cause of tracheobronchitis (“canine cough”) with unique Advanced Delivery Technology (ADT).

Features and benefits 

  • Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type 2.
  • ADT eliminates the possibility of accidental injection
  • Offers the superior benefits of intranasal administration
    • Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
    • Requires only single-nostril administration—low dose of 0.5 mL
    • Provides rapid protection as early as 48 hours post-vaccination1*
    • Provides 1-year duration of immunity 2


Indication

  • Approved for the vaccination of healthy dogs as an aid in prevention of infectious disease associated with canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica infection
  • Recommended for use in healthy dogs 3 weeks of age or older

Safety information

Please see the product label for safety information.

Administration and Dosage

For dogs 3 weeks of age or older:

  • DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS
  • Using supplied nasal applicator, instill 1 dose (0.5 mL) into one or both nostrils
  • Annual revaccination with 1 dose is recommended

For further information, including complete directions and warnings, please see the product label.

Product label(s) and MSDS

*Based on Bordetella bronchiseptica challenge.

References:

  1. Bey RF, Shade FJ, Goodnow RA, Johnson RC. Intranasal vaccination of dogs with live avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis. Am J Vet Res. 1981;42(7):1130–1132.
  2. Lehr C, Jayappa H, Erskine J, Brown A, Sweeney D, Wasmoen T. Demonstration of 1-year of immunity for attenuated Bordetella bronchiseptica vaccines in dogs. Vet Ther. 2008;9(4):257–262.